
Esketamine Linked to Reduced Postpartum Depression Risk
The meta-analysis suggests that a single dose of intravenous esketamine during delivery or caesarean section may reduce the risk of postpartum depression by more than 50% in the first 6 weeks. However, the long-term safety and efficacy of the drug are still unclear. Preliminary studies show a significant reduction in PPD incidence at 1 and…